Aten Therapeutics
London · Founded 2005
About Aten Therapeutics
Their management team has extensive experience within the biopharmaceutical industry, and a wealth of knowledge in building successful biotechnology companies. They are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.
Company Facts
- Founded: 2005
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $329.6K
- Last round: Grant (Aug 2022)
- Website: https://www.atentherapeutics.com
- Phone: +44 [0] 207 493 4546
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aten-therapeutics-128791 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.